 |
Samarium
Acetate |
Sm(O2C2H3)3.xH2O |
| Product |
Product Code |
Order or Specifications |
99%
Samarium
Acetate
|
|
 |
| 99.9% Samarium
Acetate
|
|
 |
99.99% Samarium
Acetate
|
|
 |
99.999% Samarium Acetate |
|
 |
|
Samarium
Acetate is a moderately water soluble crystalline Samarium source that decomposes to Samarium oxide on heating. It is generally immediately available in most volumes. Acetates are excellent precursors for production of ultra high purity compounds and certain catalyst and nanoscale(nanoparticles and nanopowders) materials. All metallic acetates are inorganic salts of a metal cation and the acetate anion. The acetate anion is a univalent (-1 charge) polyatomic ion composed of two carbon atoms ionically bound to three hydrogen and two oxygen atoms (Symbol: CH3COO) for a total formula weight of 59.05. Ultra high purity and high purity compositions improve both optical quality and usefulness as scientific standards. Nanoscale (See also Nanotechnology Information and Quantum Dots) elemental powders and suspensions, as alternative high surface area forms, may be considered. Samarium is used in laser applications and for its dielectric properties and in filter glass on Nd:YAG solid state lasers. It forms stable titanate compounds with useful dielectric properties. We also produce Samarium Acetate Solution. Additional technical, research and safety (MSDS) information is available.
Samarium is a Block F, Group 3, Period 6 element. The electronic configuration is [Xe]4f66s2. In its elemental form samarium's CAS number is 7440-19-9. The samarium atom has a radius of 180.4.pm and it's Van der Waals radius is unknown.
|
| Formula |
CAS No. |
Appearance |
Molecular Weight |
Solubility |
Stability |
| Sm(O2C2H3)3.xH2O |
17829-86-6 |
Yellow
|
327.48
|
Insoluble in water, moderately soluble in strong mineral acids |
Slightly hygroscopic
|
|
|
© 2001-2007. American Elements is a U.S. Registered Trademark. All rights reserved.
This website and all pages, designs, concepts, logos, and color schemes herein are
the copyrighted proprietary rights and intellectual property of American Elements. |
|
|
Recent Research & Development for Samarium
-
Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon.
Int J Pharm. 2007 Aug 2; [Epub ahead of print]
- Mechanistic Studies of Proton-Donor Coordination to Samarium Diiodide.
Angew Chem Int Ed Engl. 2007 Sep 7; [Epub ahead of print] No abstract available.
- Analysis of multiple factors related to hematologic toxicity following 153Sm-EDTMP therapy.
Cancer Biother Radiopharm. 2007 Aug;22(4):515-20.
- Development of samarium [(32)P] phosphate colloid for radiosynoviorthesis applications: Preparation, biological and preliminary clinical studies experience.
Appl Radiat Isot. 2007 Jul 25; [Epub ahead of print]
- Crystallographic and vibrational spectroscopic studies of octakis(DMSO)lanthanoid(III) iodides.
Inorg Chem. 2007 Sep 17;46(19):7731-41. Epub 2007 Aug 24.
- Synthesis and structural characterization of novel mixed-valent samarium and divalent ytterbium and europium complexes supported by amine bis(phenolate) ligands.
Dalton Trans. 2007 Aug 28;(32):3555-61. Epub 2007 Jun 26.
- First-principles thermodynamics of coherent interfaces in samarium-doped ceria nanoscale superlattices.
Phys Rev Lett. 2007 Jun 29;98(26):266101. Epub 2007 Jun 27.
- Prostate cancer metastatic to the external auditory canals.
Clin Genitourin Cancer. 2007 Jun;5(5):341-3.
- Hydroxylaminato yttrate and samarate complexes.
Dalton Trans. 2007 Aug 7;(29):3124-6. Epub 2007 Jun 13.
- Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases.
Anticancer Agents Med Chem. 2007 Jul;7(4):381-97. Review.
- Neutron Powder Diffraction with (nat)Sm: Crystal Structures and Magnetism of a Binary Samarium Deuteride and a Ternary Samarium Magnesium Deuteride.Chemistry. 2007 Jan 17; [Epub ahead of print]
- Lanthanide reagents in solid phase synthesis.Chem Soc Rev. 2006 Dec;35(12):1221-9. Epub 2006 Jun 28.
- Prospective Evaluation of Samarium-153-EDTMP Radionuclide Treatment for Bone Metastases in Patients with Hormone-Refractory Prostate Cancer.Urol Int. 2007;78(1):50-7.
- Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.
Cancer. 2006 Dec 13; [Epub ahead of print]
- Targeted and systemic radiotherapy in the treatment of bone metastasis.
Cancer Metastasis Rev. 2006 Dec;25(4):669-75.
- Vascular radiolesion as a deleterious effect of high-dose-rate intraarterial brachytherapy with samarium-153 in hypercholesterolemic rabbits.
Arq Bras Cardiol. 2006 Oct;87(4):512-9. English, Portuguese.
- Separation of samarium and neodymium: a prerequisite for getting signals from nuclear synthesis.
Analyst. 2006 Dec;131(12):1332-4. Epub 2006 Sep 28.
- Unprecedented Polymerization of Trimethylene Carbonate Initiated by a Samarium Borohydride Complex: Mechanistic Insights and Copolymerization with epsilon-Caprolactone.
Chemistry. 2006 Nov 13;13(5):1511-1521 [Epub ahead of print]
- Samarium(II) promoted stereoselective synthesis of antiproliferative cis-beta-alkoxy-gamma-alkyl-gamma-lactones.
Bioorg Med Chem Lett. 2007 Jan 1;17(1):18-21. Epub 2006 Oct 6.
- Platelet function after single [(153)Sm]EDTMP therapy in prostate cancer.
Q J Nucl Med Mol Imaging. 2006 Dec;50(4):330-3.
|
|